The remaining 27 articles had a longitudinal design, but only 20 (11%) of these attempted to examine for relevant longitudinal relationships between a change in a biomarker and a change in a ...

Rune Labs, which specializes in precision medicine for Parkinson’s disease (PD), has launched of a clinical program with ...

Researchers have discovered a new biomarker for Parkinson’s that could be used to identify people at risk of the disease and profoundly change the way it is treated. The assay for a particular ...

At the Ronald Reagan UCLA Medical Center, a patient with Parkinson’s disease sat at a desk in front of a computer, pen in ...

Nielsen, Jr., Research Professor of Parkinson's Disease and Movement Disorders, have defined new biologic and clinical biomarkers for better identifying patients with different stages of Parkinson ...

Parkinson’s disease is best known for its effects on the central nervous system. In addition, recent scientific advances ...

Other projects looking at digital biomarkers for Parkinson's include the crowd-sourced DREAM Challenge, which saw 40 research teams from around the world contribute ways to process accelerometer ...

The global Biomarkers Market, valued at US$58.07 billion in 2024 stood at US$62.39 billion in 2025 and is projected to ...

The most common form of dementia that surfaces in midlife (generally talking 40s and 50s here) is called frontotemporal ...